
Jalra M 50mg/500mg Tablet 15s
by USV Ltd
In Stock • people bought this
- Controls blood sugar effectively
- Improves insulin function
- Reduces glucose production
- Prevents diabetes complications
Seller : Davadost pharma private limited
People who purchased Jalra M 50mg/500mg Tablet 15s also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Jalra M 50mg/500mg Tablet 15s
Jalra M 50mg/500mg Tablet is an antidiabetic medication used to manage Type 2 Diabetes Mellitus. It contains Vildagliptin (50mg), a DPP-4 inhibitor, and Metformin (500mg), a biguanide, which together help control blood sugar levels, improve insulin function, and reduce glucose production.
How Jalra M 50mg/500mg Tablet 15s works
Jalra M 50mg/500mg Tablet 15s combines two antidiabetic drugs: Metformin and Vildagliptin. Metformin reduces sugar production in the liver, slows down sugar absorption from the intestines, and makes the body more responsive to insulin. Vildagliptin increases insulin release from the pancreas and reduces hormones that raise blood sugar, leading to better control of both fasting and after-meal sugar levels when used together.
How To Use Jalra M 50mg/500mg Tablet 15s
- Dosage: Usually one tablet twice daily, as prescribed. Dose adjustments may be needed based on blood sugar levels.
- Administration: Take with meals to avoid stomach upset. Swallow whole with water; do not crush or chew.
- Duration: Long-term use is required for diabetes management.
Special Precautions for Jalra M 50mg/500mg Tablet 15s
- Use with caution in heart disease patients, as blood sugar fluctuations may affect the heart.
- Do not use Jalra M 50mg/500mg Tablet in Type 1 Diabetes or diabetic ketoacidosis.
- May cause low blood sugar (hypoglycemia) if taken with other antidiabetic drugs or skipped meals.
Benefits Of Jalra M 50mg/500mg Tablet 15s
- Effectively controls blood sugar levels in Type 2 diabetes.
- Jalra M 50mg/500mg Tablet reduces the risk of diabetes complications like nerve damage and kidney disease.
- Helps in weight management by reducing glucose absorption.
- Improves insulin sensitivity, making the body use insulin more effectively.
Uses of Jalra M 50mg/500mg Tablet 15s
- Control high blood sugar level in diabetic patients
Side Effects Of Jalra M 50mg/500mg Tablet 15s
- Common Side Effects: Nausea, vomiting, diarrhea, dizziness, headache.
- Serious Side Effects: Lactic acidosis (weakness, trouble breathing), pancreatitis, liver issues.
What If I Missed A Dose Of Jalra M 50mg/500mg Tablet 15s
- Take the missed dose as soon as you remember.
- If it’s close to the next dose, skip the missed one and continue as usual.
- Do not double the dose to make up for a missed one.
Health And Lifestyle
Drug Interaction
- Alcohol – Increases the risk of lactic acidosis.
- Beta-blockers (e.g., Atenolol, Metoprolol) – May mask symptoms of low blood sugar.
- Diuretics (e.g., Furosemide) – May affect blood sugar control.
- Corticosteroids (e.g., Prednisolone) – May increase blood sugar levels.
- Antacid- Cimetidine
Drug Food Interaction
- Alcoholic beverages
Disease Explanation

Type 2 Diabetes Mellitus – A condition where the body does not use insulin effectively, leading to high blood sugar levels. Insulin Resistance – A condition where cells fail to respond properly to insulin, requiring more insulin to maintain normal glucose levels. Hyperglycemia (High Blood Sugar) – Can lead to complications like nerve damage, kidney failure, and vision problems if left untreated.
Safety Advice for Jalra M 50mg/500mg Tablet 15s
- High risk
- Moderate risk
- Safe
Alcohol should generally be avoided while taking these medications because it can enhance their blood sugar-lowering effects and raise the risk of hypoglycemia.
It is also generally considered safe to use while pregnancy.
Jalra M 50mg/500mg Tablet is typically considered safe to use during breastfeeding.
The medication is mainly eliminated through the kidneys and, in rare instances, can cause lactic acidosis, particularly in those with kidney issues.
It is generally safe for liver. However, consult the doctor before use.
It's safe to drive after taking this drug.
Tips for Jalra M 50mg/500mg Tablet 15s
- Take with food to prevent stomach upset.
- Avoid skipping meals, as it may cause hypoglycemia.
- Monitor kidney function regularly for long-term safety.
FactBox of Jalra M 50mg/500mg Tablet 15s
- Manufacturer: USV Ltd
- Composition: Vildagliptin (50mg) + Metformin (500mg)
- Class: DPP-4 Inhibitor + Biguanide
- Uses: Type 2 Diabetes Management
- Prescription: Required
- Storage: Store below 30°C, away from moisture
Storage of Jalra M 50mg/500mg Tablet 15s
- Store in a cool, dry place below 30°C.
- Keep out of reach of children.
- Keep in original packaging to prevent moisture damage.
Dosage of Jalra M 50mg/500mg Tablet 15s
- Usually one tablet twice daily, or as prescribed.
- Dose may be adjusted based on blood sugar levels.
Synopsis of Jalra M 50mg/500mg Tablet 15s
Jalra M 50mg/500mg Tablet is a combination of Vildagliptin and Metformin that effectively lowers blood sugar levels in Type 2 Diabetes. It reduces glucose production, improves insulin function, and helps prevent diabetes complications.
FAQ's on Jalra M 50mg/500mg Tablet 15s
What is Jalra tablet?
How does vildagliptin work in the body?
What class of drug is vildagliptin?
What is Jalra used for?
Is metformin bad on your kidneys?
What is Jalra tablet used for?
What is the best medicine for diabetes type 2?
How long does Jalra M take to lower blood sugar?
What should you not eat when taking metformin?
Is vildagliptin safe?
When should I take jalra 50?
Can Jalra M be taken on an empty stomach?
Does Jalra M cause weight gain?
Can I stop taking Jalra M if my sugar is normal?
Is Jalra M safe for kidney patients?
Can Jalra M be used in Type 1 Diabetes?
Does Jalra M cause low blood sugar?
Can I drink alcohol while taking Jalra M?
How long should I take Jalra M?
Can Jalra M cause stomach issues?
Is Jalra good for diabetes?
Written By
Priyanka Sonkushre
Content Updated on
Tuesday, 12 August, 2025










